Daniel Vazquez is a highly accomplished professional with a wealth of experience spanning over 30 years. Prior to joining the ESTERN Medical CRO Life Sciences Corporate & Scientific Advisory Board, Mr. Vazquez held the esteemed position of Senior Head Director and Global Regulatory Affairs Executive at IQVIA (formerly Quintiles).
During his tenure at Quintiles/IQVIA, Daniel played a pivotal role in transforming the organization into a leading Clinical Research Organization (CRO) in the industry. His strategic vision focused on establishing a robust leadership team dedicated to specializing in Life Sciences and clinical trials for biotech, pharmaceutical, and medical device companies. This involved navigating the complexities of Investigational New Drugs (INDs), New Drug Applications (NDAs), and executing clinical trials across all phases.
Presently, Mr. Vazquez serves as the Head Manager of Regulatory Affairs for Latin America and Canada at Philip Morris International. Simultaneously, he holds the position of President at eHealth Solutions, a consortium dedicated to advancing clinical trials in Life Sciences development.
As a member of the advisory board, Mr. Vazquez significantly enhances the strength of ESTERN Medical’s leadership team and regulatory and scientific advisory board. This aligns seamlessly with the company’s strategic focus on global growth and international expansion.
With his extensive experience, Mr. Vazquez is poised to provide invaluable guidance for ESTERN’s strategic clinical trial research and development initiatives. His expertise will be instrumental in supporting sponsors, including Biotech, Pharma, and Medical Device Life Sciences industry companies.
Mr. Vazquez earned his Pharmacist degree from the University of Buenos Aires in Argentina and is internationally acclaimed for his expertise and numerous scientific publications in global strategic regulatory clinical research development. He has made significant contributions to prestigious life sciences academic institutions and holds key memberships in various scientific organizations within the pharmaceutical and medical device industry. Notably, he is a member, honorary founder, and former president of the Association of CROs (CAOIC) and serves on the Clinical Trials Board of CAEME in Latin America.
